CJC-1295 vs Ipamorelin: Research Peptide Comparison
CJC-1295 vs ipamorelin is a common comparison in growth hormone axis research. Both are lyophilized peptides supplied with HPLC-tested COA from Direct Peptides for laboratory use.
What is CJC-1295?
CJC-1295 is a growth hormone releasing hormone (GHRH) analog studied for sustained GH pulse amplification. The no-DAC variant has a shorter half-life suited to pulsatile research models. Order lyophilized CJC-1295 research peptide with COA.
What is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue (GHRP) studied for its targeted GH release with minimal impact on cortisol and prolactin in animal models. Shop ipamorelin research peptide COA from our USA facility.
CJC-1295 vs Ipamorelin Comparison
| Feature | CJC-1295 | Ipamorelin |
|---|---|---|
| Mechanism | GHRH analog (amplifies natural GH pulse) | GHRP (stimulates GH release) |
| Selectivity | Broad GHRH receptor activation | Highly selective GH secretagogue |
| Research pairing | Often combined with GHRPs | Often stacked with GHRH analogs |
| Form supplied | Lyophilized + COA | Lyophilized + COA |
Why Researchers Combine Them
Many endocrine studies pair CJC-1295 with ipamorelin to model synergistic GH axis activation. Direct Peptides offers a pre-mixed CJC-1295 / ipamorelin research blend with certificate of analysis. Also compare sermorelin (another GHRH analog) in our GH vs GHRH vs GHRP article and ipamorelin research overview.
Research use only. CJC-1295 and ipamorelin are sold for laboratory research. Not for human consumption or medical treatment.